NADAC acquisition cost data for ENDOCET 10-325 MG TABLET. This is a generic medication, typically more affordable than brand-name equivalents.
| NDC | NADAC/Unit | Effective Date | Type |
|---|---|---|---|
| 60951071270 | $0.1849 | 2022-12-21 | Rx |
| 60951071270 | $0.1849 | 2022-12-21 | Rx |
Generic: Oxycodone HCl/Acetaminophen | Manufacturer: Overall
| Year | Total Spending | Claims | Beneficiaries | Cost/Unit |
|---|---|---|---|---|
| 2019 | $4.7M | 108,903 | 20,019 | $0.4453 |
| 2020 | $3.3M | 89,245 | 15,788 | $0.3862 |
| 2021 | $2.7M | 71,683 | 12,124 | $0.3863 |
| 2022 | $2.2M | 57,537 | 11,386 | $0.4083 |
| 2023 | $2.8M | 79,681 | 35,890 | $0.3987 |
| State | Total Cost | Claims | Beneficiaries |
|---|---|---|---|
| New York | $422.1K | 12,666 | 3,613 |
| Pennsylvania | $302.2K | 12,995 | 3,527 |
| New Jersey | $230.0K | 6,407 | 1,902 |
| Ohio | $118.9K | 3,482 | 2,387 |
| California | $116.6K | 2,381 | 1,420 |
| Georgia | $100.0K | 2,487 | 1,397 |
| North Carolina | $95.8K | 2,073 | 1,106 |
| Tennessee | $92.3K | 2,453 | 1,531 |
| Florida | $81.3K | 2,136 | 1,359 |
| Kentucky | $71.2K | 1,502 | 785 |
| Virginia | $68.0K | 1,757 | 1,116 |
| Maryland | $67.6K | 1,939 | 1,089 |
| Texas | $66.4K | 1,784 | 1,057 |
| Utah | $49.6K | 1,309 | 729 |
| Kansas | $49.0K | 1,141 | 667 |
| Washington | $48.3K | 1,158 | 669 |
| Michigan | $47.7K | 1,519 | 951 |
| Indiana | $45.5K | 990 | 705 |
| Colorado | $45.0K | 1,116 | 667 |
| Alabama | $44.2K | 1,016 | 421 |
| Arizona | $44.2K | 1,092 | 690 |
| Oklahoma | $43.5K | 966 | 454 |
| Missouri | $43.5K | 871 | 470 |
| Oregon | $42.6K | 987 | 539 |
| Massachusetts | $35.6K | 1,105 | 528 |
| Connecticut | $32.4K | 985 | 528 |
| South Carolina | $32.4K | 790 | 496 |
| Puerto Rico | $32.2K | 2,682 | 1,043 |
| Iowa | $28.8K | 794 | 453 |
| Nevada | $26.3K | 911 | 385 |
| Minnesota | $25.6K | 683 | 389 |
| Illinois | $24.9K | 489 | 285 |
| Wisconsin | $20.0K | 557 | 307 |
| Louisiana | $16.0K | 624 | 470 |
| Mississippi | $15.6K | 385 | 245 |
| Idaho | $15.1K | 395 | 257 |
| Nebraska | $15.1K | 340 | 200 |
| Vermont | $10.9K | 169 | 53 |
| Arkansas | $10.3K | 253 | 140 |
| Delaware | $9.8K | 279 | 114 |
| Montana | $9.6K | 381 | 213 |
| West Virginia | $9.2K | 255 | 169 |
| New Hampshire | $8.6K | 262 | 143 |
| New Mexico | $7.8K | 195 | 142 |
| Maine | $7.8K | 251 | 167 |
| Wyoming | $6.6K | 142 | 50 |
| Alaska | $4.5K | 115 | 79 |
| North Dakota | $3.5K | 107 | 75 |
| District of Columbia | $2.3K | 113 | 75 |
| South Dakota | $2.0K | 66 | 52 |
| Rhode Island | $1.5K | 54 | 22 |
| Hawaii | $757.05 | 42 | 38 |
The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.
Read our full methodology or contact us with corrections.